The Effects of Microbiological Spectrum Changes to Improve Cognitive Health in Aging Population
NCT05051501 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2023-06-01
Summary
The goal of this project is to develop probiotic dietary supplements intended for the elderly, which can modify the composition of the intestinal microbiota typically occurring in the aging population. According to currently held scientific knowledge, it is postulated that the probiotics-induced normalization of the physiological axis in the brain-intestinal microbiota affects the activity of the nervous system. Thus, normalization of this axis should lead to observable improvements in cognitive functions and quality of life.
Conditions
- Memory Deficits
- Mood Change
- Gut Health
- Aging Problems
- Aging
- Cognitive Decline
Interventions
- DIETARY_SUPPLEMENT
-
Probiotics C2P
Probiotics will supplement normal diet. Unlike other products available on the market, which are usually of bovine origin, our probiotic has been manufactured using human-stemmed lines. The supplements are composed of a mixture of naturally occurring human gut bacteria.
Sponsors & Collaborators
-
C2P s.r.o.
collaborator UNKNOWN -
University Hospital Vinohrady
collaborator UNKNOWN -
Ministry of Industry and Trade, Czech Republic
collaborator UNKNOWN -
National Institute of Mental Health, Czech Republic
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 55 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-01-06
- Primary Completion
- 2022-03-02
- Completion
- 2022-03-02
Countries
- Czechia
Study Locations
More Related Trials
-
The Relationship Between Diet, Cognition, Stress, and the Gut Microbiota
NCT05931536 ·Status: RECRUITING
-
The Efficacy and Safty of FMT in Patients With CID
NCT05917379 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Impact of Diet on the Gut-Microbiota-Brain Axis
NCT05931562 ·Status: RECRUITING ·Phase: NA
-
Colonoscopic Probiotics Infusion for Functional Gastrointestinal Disease
NCT05366335 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effects of Multi-strain Probiotics in Adults With Diarrhea Predominant Irritable Bowel Syndrome
NCT01637714 ·Status: UNKNOWN ·Phase: NA
-
Characteristic of Intestinal Flora in Male Elderly With Small Intestinal Bacterial Overgrowth
NCT03659175 ·Status: UNKNOWN
-
Microbiome, Anxiety and Cognitive Orientation Study
NCT05388630 ·Status: UNKNOWN
-
The Gut Microbiota in Obsessive-Compulsive Disorder
NCT02285699 ·Status: COMPLETED ·Phase: NA
-
Human Intestinal Microbiota in Obesity and Nutritional Transition
NCT01314690 ·Status: COMPLETED ·Phase: NA
-
Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome
NCT02565550 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Trial to Evaluate the Effect of a Probiotic Mixture on Signs and Symptoms of Irritable Bowel Syndrome
NCT05565612 ·Status: COMPLETED ·Phase: NA
-
The Effect of Probiotics on Symptoms and Intestinal Flora in Patients With Irritable Bowel Syndrome
NCT02108119 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Probiotic Supplement in Alleviating Functional Gastrointestinal Symptoms
NCT01728610 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive Disorder
NCT01337609 ·Status: TERMINATED ·Phase: PHASE4
-
The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients
NCT02254629 ·Status: COMPLETED ·Phase: PHASE1
-
Gut Microbiota in Mood Disorders in Lebanese Population
NCT05646784 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Treatment Benefits of Probiotic Clostridium Butyricum CBM588® for IBS-D
NCT06676514 ·Status: COMPLETED ·Phase: NA
-
Investigation of Pathogenic Gut Microbiota Patterns in Anxiety, Depression and Panic Disorders
NCT07268729 ·Status: COMPLETED
-
Changes in Microbiota and Quality of Life in IBS
NCT05266287 ·Status: UNKNOWN ·Phase: NA
-
Effects of Rifaximin on Gut Microbiota and Emotion
NCT05587036 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT05509725 ·Status: RECRUITING ·Phase: PHASE4
-
Probiotic Intervention for Gut Function
NCT05155449 ·Status: COMPLETED ·Phase: NA
-
Brain-Gut-Microbiota Interaction in IBS
NCT04296552 ·Status: UNKNOWN ·Phase: NA
-
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Depression
NCT04211467 ·Status: WITHDRAWN
-
Effect of Colon Delivered Vitamin B2 on Gut Microbiota and Related Health Biomarkers in Healthy Older Adults
NCT05803811 ·Status: COMPLETED ·Phase: NA